Skip to main content
OpenTrials

Clinical trial condition

Chickenpox

Explore clinical trials studying Chickenpox. Study availability and eligibility vary by location and protocol.

140 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Chickenpox trial results

Completed

Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox

NCT00001125

Conditions
Blood-Borne Infections, Chickenpox, Communicable Diseases, +15 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases Torrance, California, United States
View all 22 locations
View Trial Details
Completed

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

NCT00000837

Conditions
AIDS-Related Complex, Blood-Borne Infections, Chickenpox, +17 more
Locations
  • Long Beach Memorial Med. Ctr., Miller Children's Hosp. Long Beach, California, United States
  • Usc La Nichd Crs Los Angeles, California, United States
  • UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS Los Angeles, California, United States
  • Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab. Oakland, California, United States
View all 25 locations
View Trial Details
Completed

Evaluation of the Immunogenicity and Safety of VARIVAX™ in Healthy Russians (V210-058)

NCT03843632

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations
  • Republican Clinical Infectious Hospital n.a. A.F. Agafonov ( Site 5816) Kazan', Russia
  • Research Institute of Children Infections ( Site 5801) Saint Petersburg, Russia
  • SPb Pasteur RI of Epidemiology and Microbiology ( Site 5817) Saint Petersburg, Russia
  • Smolensk State Medical University ( Site 5814) Smolensk, Russia
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

NCT03239873

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +4 more
Locations
  • Alabama Clinical Therapeutics ( Site 0018) Birmingham, Alabama, United States
  • Children's Clinic of Jonesboro, PA ( Site 0030) Jonesboro, Arkansas, United States
  • Southland Clinical Research Center ( Site 0017) Anaheim, California, United States
  • Premier Health Research Center, LLC ( Site 0044) Downey, California, United States
View all 37 locations
View Trial Details

Related conditions